Cancer Home > Gefitinib Drug Information

Gefitinib (Iressa®) is a chemotherapy medication used to treat non-small cell lung cancer. It comes as a tablet that is usually taken once a day.
Due to the information obtained during clinical trials on gefitinib, the manufacturer of the drug no longer manufacturers this product for use in the United States. These clinical studies showed that gefitinib did not improve survival, and that other medications may be more appropriate for use before gefitinib is prescribed.
Most people who take gefitinib will develop some type of side effect. Some of the most commonly reported reactions to this medicine are diarrhea, nausea, and a rash.
(Click Gefitinib for more information on this drug, including other safety concerns and how it works.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.